Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amarin believes Vascepa well positioned in triglyceride lowering market
Yahoo/Fly on the Wall
Friday, March 1, 2013 - 11:19am
tags:
Vascepa, Amarin
FDA staff say calcitonin salmon cancer risk appears plausible
Reuters
Friday, March 1, 2013 - 11:17am
tags:
FDA, calcitonin salmon, Novartis, Unigene, Upsher-Smith
Amarin Q4 Call Leaves A Fishy Taste In My Mouth
Seeking Alpha
Friday, March 1, 2013 - 11:16am
tags:
earnings, Amarin
How Earnings Point to MAKO Surgical's Evolving Story
Motley Fool
Friday, March 1, 2013 - 11:14am
tags:
earnings, Mako Surgical
Jury awards $7.8 million in punitive damages in Johnson & Johnson implant lawsuit
Yahoo/AP
Friday, March 1, 2013 - 11:14am
tags:
JNJ, hip implants
Merck's HPV Growth Continues
Motley Fool
Friday, March 1, 2013 - 11:13am
tags:
Merck, HPV, Gardasil
Otsuka, Lundbeck Win Approval for Monthly Abilify Shot
Bloomberg
Friday, March 1, 2013 - 11:12am
tags:
schizophrenia, Lundbeck, Otsuka, Abilify, Abilify Maintena
Do These Pipeline Drugs Hold the Key to AbbVie's Future?
Motley Fool
Friday, March 1, 2013 - 11:10am
tags:
AbbVie, BT-061, Humira, GLPG0634
GlaxoSmithKline - Against All Odds
Seeking Alpha
Friday, March 1, 2013 - 11:09am
tags:
GSK
Do We Really Need Head-To-Head Comparison Trials With Statins To Improve Cardiac Health?
Forbes
Friday, March 1, 2013 - 11:06am
tags:
statins
BIO, PhRMA Blast FDA Draft Guidance on E-Subs for Trial Site Data
Outsourcing Pharma
Thursday, February 28, 2013 - 11:44am
tags:
PhRMA, FDA, BIO, clinical trials
Lundbeck given EU nod for alcohol dependence drug
Reuters
Thursday, February 28, 2013 - 11:43am
tags:
Lundbeck, Europe, alcoholism, Selincro
The Pharma Influence On Budding Medical Trainees
Pharmalot
Thursday, February 28, 2013 - 11:39am
tags:
physicians
Fresenius, B. Braun IV Fluids Tied to More Deaths, Study Finds
Bloomberg
Thursday, February 28, 2013 - 11:38am
tags:
IV fluids, Fresenius, B. Braun
Menopause Drugs from Depomed, Hisamitsu Offer Benefits
Bloomberg
Thursday, February 28, 2013 - 11:36am
tags:
Depomed, Hisamitsu, menopause, hot flashes, gabapentin, paroxetine mesylate
Incyte's Jakafi Is Likely A $1 Billion Drug
Seeking Alpha
Thursday, February 28, 2013 - 11:35am
tags:
Jakafi, Incyte, myelofibrosis
AVEO to meet with FDA about tivozanib
Bizjournals.com
Thursday, February 28, 2013 - 11:33am
tags:
FDA, Aveo, tivozanib, kidney cancer
3 Bio-Pharmaceuticals You Can't Ignore
Motley Fool
Thursday, February 28, 2013 - 11:32am
tags:
Amarin, Vivus, Arena Pharmaceuticals
A Drug That's Ready to Lose
Motley Fool
Thursday, February 28, 2013 - 11:30am
tags:
Belviq, Arena Pharmaceuticals, Vivus, Eisai
It's Now Time For Vivus Investors To Watch Arena Numbers
Seeking Alpha
Thursday, February 28, 2013 - 11:28am
tags:
Vivus, Arena

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.